183 related articles for article (PubMed ID: 23543662)
1. Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine.
Boelaert K; Maisonneuve P; Torlinska B; Franklyn JA
J Clin Endocrinol Metab; 2013 May; 98(5):1869-82. PubMed ID: 23543662
[TBL] [Abstract][Full Text] [Related]
2. Thyroid function and mortality in patients treated for hyperthyroidism.
Franklyn JA; Sheppard MC; Maisonneuve P
JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
[TBL] [Abstract][Full Text] [Related]
3. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.
Stan MN; Durski JM; Brito JP; Bhagra S; Thapa P; Bahn RS
Thyroid; 2013 May; 23(5):620-5. PubMed ID: 23205939
[TBL] [Abstract][Full Text] [Related]
4. Association of Radioactive Iodine, Antithyroid Drug, and Surgical Treatments With Solid Cancer Mortality in Patients With Hyperthyroidism.
Kitahara CM; Preston DL; Sosa JA; Berrington de Gonzalez A
JAMA Netw Open; 2020 Jul; 3(7):e209660. PubMed ID: 32701159
[TBL] [Abstract][Full Text] [Related]
5. Management of thyrotoxicosis in children and adolescents: 35 years' experience in 304 patients.
Azizi F; Amouzegar A
J Pediatr Endocrinol Metab; 2018 Jan; 31(2):159-165. PubMed ID: 29306930
[TBL] [Abstract][Full Text] [Related]
6. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine therapy versus antithyroid medications for Graves' disease.
Ma C; Xie J; Wang H; Li J; Chen S
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD010094. PubMed ID: 26891370
[TBL] [Abstract][Full Text] [Related]
8. Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.
Journy NMY; Bernier MO; Doody MM; Alexander BH; Linet MS; Kitahara CM
Thyroid; 2017 Aug; 27(8):1001-1010. PubMed ID: 28578598
[TBL] [Abstract][Full Text] [Related]
9. Mortality after the treatment of hyperthyroidism with radioactive iodine.
Franklyn JA; Maisonneuve P; Sheppard MC; Betteridge J; Boyle P
N Engl J Med; 1998 Mar; 338(11):712-8. PubMed ID: 9494147
[TBL] [Abstract][Full Text] [Related]
10. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group.
Ron E; Doody MM; Becker DV; Brill AB; Curtis RE; Goldman MB; Harris BS; Hoffman DA; McConahey WM; Maxon HR; Preston-Martin S; Warshauer ME; Wong FL; Boice JD
JAMA; 1998 Jul 22-29; 280(4):347-55. PubMed ID: 9686552
[TBL] [Abstract][Full Text] [Related]
11. Patients Treated for Hyperthyroidism Are at Increased Risk of Becoming Obese: Findings from a Large Prospective Secondary Care Cohort.
Torlinska B; Nichols L; Mohammed MA; McCabe C; Boelaert K
Thyroid; 2019 Oct; 29(10):1380-1389. PubMed ID: 31375059
[No Abstract] [Full Text] [Related]
12. Treatment of Subclinical Hyperthyroidism in the Elderly: Comparison of Radioiodine and Long-Term Methimazole Treatment.
Azizi F; Abdi H; Cheraghi L; Amouzegar A
Thyroid; 2021 Apr; 31(4):545-551. PubMed ID: 32811342
[No Abstract] [Full Text] [Related]
13. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
[TBL] [Abstract][Full Text] [Related]
14. Hyperthyroidism. Current treatment guidelines.
Gittoes NJ; Franklyn JA
Drugs; 1998 Apr; 55(4):543-53. PubMed ID: 9561343
[TBL] [Abstract][Full Text] [Related]
15. Thyroid status, cardiovascular risk, and mortality in older adults.
Cappola AR; Fried LP; Arnold AM; Danese MD; Kuller LH; Burke GL; Tracy RP; Ladenson PW
JAMA; 2006 Mar; 295(9):1033-41. PubMed ID: 16507804
[TBL] [Abstract][Full Text] [Related]
16. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study.
Franklyn JA; Maisonneuve P; Sheppard M; Betteridge J; Boyle P
Lancet; 1999 Jun; 353(9170):2111-5. PubMed ID: 10382695
[TBL] [Abstract][Full Text] [Related]
17. Management of hyper & hypo thyroid conditions.
Locke W
Postgrad Med; 1982 Mar; 71(3):118-25, 128-9. PubMed ID: 6173875
[TBL] [Abstract][Full Text] [Related]
18. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
[No Abstract] [Full Text] [Related]
19. [Thyroid hormones and cardiovascular system].
Límanová Z; Jiskra J
Vnitr Lek; 2016; 62(9 Suppl 3):92-98. PubMed ID: 27734699
[TBL] [Abstract][Full Text] [Related]
20. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Auvinen A; Oksala H; Salmi J
J Clin Endocrinol Metab; 2007 Jun; 92(6):2190-6. PubMed ID: 17374710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
